Analysts expect Valneva to post earnings of ($0.22) per share and revenue of $55.64 million for the quarter. Valneva Trading Up 0.1 % NASDAQ VALN opened at $6.80 on Monday.
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 - ...
Saint-Herblain (France), March 3, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announced that its senior management will participate at upcoming investor ...
ANTARA/Ricky Prayoga Dengan MoU ini, BioFarma yang selama ini diketahui merupakan industri vaksin yang besar dan sudah mensuplai lebih dari 150 negara, nanti akan lebih memperluas jangkauan distribusi ...
VALNEVA Declaration of shares and voting rights February 28, 2025_____ Company name: VALNEVARegistered office ...
Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics. The French pharma company ...
New data for Valneva and Pfizer's experimental vaccine for Lyme disease – the furthest ahead in clinical testing – have bolstered the case for the shot as the results of a phase 3 programme ...
Pasalnya, WHO sudah merekomendasikan vaksin HPV untuk masuk ke dalam program imunisasi ... Aktivitas Fisik dan Penuaan Kardiovaskular: Mekanisme dan Bukti Terbaru 2021, Jurnal Olahraga dan Kebugaran 2 ...
Kementerian Kesehatan Arab Saudi mendesak umat Islam yang akan melakukan umrah Ramadan agar melakukan vaksin meningitis setidaknya 10 hari sebelum keberangkatan ke Makkah. Dilansir dari Gulf News, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback